Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
✍ Scribed by Marc C. Chamberlain; Sandra Johnston
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 207 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The primary objective of this prospective phase 2 study of CPT‐11 in adult patients with recurrent temozolomide‐refractory anaplastic astrocytoma (AA) was to evaluate 6‐month progression‐free survival (PFS). ## METHODS. Forty patients (27 men and 13 women) ages 17 to 5
## Abstract ## BACKGROUND The primary objective of the current prospective Phase II study of cyclophosphamide (CYC) in adult patients with recurrent, temozolomide‐refractory glioblastoma multiforme was to evaluate 6‐month progression‐free survival (PFS). ## METHODS Forty patients (28 men and 12